Searchable abstracts of presentations at key conferences in endocrinology

ea0063p786 | Thyroid 2 | ECE2019

Long-term efficacy of percutaneous ethanol injection in symptomatic thyroid cysts: Results and protocol proposal

Vazquez Federico , Perez-Montes de Oca Alejandra , Puig-Domingo Manel , Reverter Jordi L

Aim: To evaluate the long-term efficacy of percutaneous ethanol injection treatment (PEIT) as an alternative to thyroid surgery in symptomatic thyroid cysts with a structured protocol.Methods: Seventy five subjects (48±12 years; 58% women) with symptomatic benign thyroid cysts relapsed after drainage were included. PEIT was conducted using the established procedure in our hospital, and the initial cyst volume, pain perceived by the patient and sympt...

ea0037ep1052 | Thyroid (non-cancer) | ECE2015

Percutaneous ethanol injection as a first line treatment of cystic thyroid nodules: experience after its introduction in a university hospital

Reverter Jordi L , Alonso Nuria , Ordonez Isabel , Cuadrado Maribel , Cano Lucia , Mauricio Didac , Domingo Manel Puig

Objectives: To evaluate the efficacy, safety and patientÂ’s pain perception of percutaneous ethanol injection treatment (PEIT) as an alternative to surgery in symptomatic thyroid cysts.Patients and methods: Thirty consecutive patients (mean age: 46±10 years; 82% women) with symptomatic thyroid cysts relapsed after drainage were included. In all cases, cytology prior to treatment, maximum cyst diameter and volume were determined. PEIT was conduct...

ea0020p87 | Thyroid | ECE2009

Long-term exogenous subclinical hyperthyroidism is not associated with decrased bone mineral density in men with differentiated thyroid carcinoma

Colome Eulalia , Reverter Jordi L , Holgado Susana , Puig Rocio , Alonso Nuria , Sanmarti Anna

Objectives: To determine the effect on bone mineral density (BMD) of the sub clinical hyperthyroidism (SH) due to TSH-suppressive treatment with levothyroxine after thyroidectomy in men with differentiated thyroid carcinoma (DTC).Materials and methods: Cross-sectional and retrospective study in 32 men (56±14 years) treated with levothyroxine for a minimum of 5 years, with TSH concentrations <0.05 mUI/ml and normal T3 levels in all determinations...

ea0056oc9.4 | Thyroid from basics to clinics | ECE2018

Identification of an epigenetic biomarker panel for predicting the development of distant metastases in differentiated thyroid cancer

Rodriguez Helena , Zafon Carles , Villalmanzo Nuria , Cerda Lorena , Iglesias Carmela , Real Jordi , Gil Joan , Hesselink Esther N. Klein , van Hemel Bettien M. , Montero-Conde Cristina , Reverter Jordi L. , Mauricio Didac , Puig-Domingo Manel , Robledo Mercedes , Links Thera P. , Jorda Mireia

Background: Differentiated thyroid cancer (DTC) is usually associated with an excellent prognosis. The main cause of death is due to distant metastases, but distant metastatic DTC (dmDTC) presents an interpatient heterogeneity. Some patients with distant metastases live with stable disease for many years, while others die very early. Still no effective biomarkers are available to predict either which patients will eventually develop distant metastases or what will be the final...